Patrick T. Mooney MD, Chief Executive Officer, is an experienced biotech CEO including pharmaceutical and medical device CEO positions at Inpellis, Inc, Echo Therapeutics, Inc., and Aphton Corp. Prior positions include Senior Biotech Analyst at Thomas Weisel Partners and Janney Montgomery Scott. M.D. – Jefferson Medical College, surgical resident at Thomas Jefferson Hospital.
Todd Ridky MD/PhD, Co-Founder, is an active physician-scientist, practicing dermatologist, and expert in human skin biology. Dr. Ridky is an Assistant Professor in the Dept of Dermatology, University of Pennsylvania. He received a BS in Chemistry from the University of North Carolina at Chapel Hill, a PhD in Biochemistry and MD from Case Western Reserve University, and completed dermatology residency and epithelial biology postdoctoral fellowship at Stanford University.
Chris Natale, Co-Founder, received a BS in Biochemistry and Molecular Biology from Penn State, and is currently a Ph.D. candidate in the Cell and Molecular Biology graduate program and part of the Developmental, Stem Cell, and Regenerative Biology graduate group at the University of Pennsylvania. Basic science discoveries during his thesis research in Dr. Ridky’s lab inspired the formation of Linnaeus.
linnaeustherapeutics.wordpress.com 